1 active not recruiting, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow ALL, Childhood: new trials by email Literature Review of ALL, Childhood trials Research Report on ALL, Childhood
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT Blinatumomab - ALL, Childhood, Minimal Residual Disease | Phase 2 | Terminated | Prof. Christina Peters | 3 | 2020-12-17 | 2024-01-16 |
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Ixazomib, Vincristine, Dexamethasone - ALL, Childhood, Lymphoblastic Lymphoma, Childhood | Phase 1 / Phase 2 | Active not recruiting | Therapeutic Advances in Childhood Leukemia Consortium | 24 | 2019-02-12 | 2025-06-17 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Neoplasm, Residual (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Asparaginase (1) · Cytarabine (1) · Dexamethasone (1) · Doxorubicin (1) · Hydrocortisone (1) · Leucovorin (1) · Methotrexate (1) · Vincristine (1) · blinatumomab (1) · ixazomib (1)
Prof. Christina Peters (1) · Therapeutic Advances in Childhood Leukemia Consortium (1)
Australia (1) · Austria (1) · Belgium (1) · Czechia (1) · Denmark (1) · France (1) · Italy (1) · Norway (1) · Poland (1) · Slovakia (1) · Spain (1) · United States (1)
Christina Peters, MD (1) · Terzah Horton, MD (1)